Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Apr
7
2016
FDA Issues Final Rule on Sanitary Transportation of Food Barnes & Thornburg LLP
Oct
11
2016
FDA Finalized Guidance on Including Patient Preference Information in Certain Medical Device Pre-Market Submissions Barnes & Thornburg LLP
Nov
18
2016
Updated, Expanded Guidance Issued for Food Facility Registration Barnes & Thornburg LLP
Nov
3
2017
FDA’s Final Guidance Restricts Sharing Patient-Specific Information Barnes & Thornburg LLP
Aug
2
2013
Federal District Courts Request FDA to Define “Natural” With Respect to Genetically-Modified Organisms (GMO) Foods Barnes & Thornburg LLP
Oct
5
2013
Food and Drug Administration (FDA) Finalizes Guidance on Mobile Medical Apps Barnes & Thornburg LLP
Sep
22
2014
FDA Issues Revisions to Proposed Food Safety Rules, Reopens Comment Period for Revisions Only Barnes & Thornburg LLP
Nov
11
2014
HHS Issues Bulletin on HIPAA Privacy In Emergency Situations In Light of the Ebola Outbreak Barnes & Thornburg LLP
Dec
19
2014
Legalized Loophole – Is Legalized Marijuana Truly “Lawful?” Barnes & Thornburg LLP
Jun
17
2015
Medical Marijuana Users Get Smoked by High Court of Colorado Barnes & Thornburg LLP
Dec
24
2019
FDA Releases Results from Second Round of Testing for PFAS in Foods Barnes & Thornburg LLP
Sep
28
2023
SEC Staff Comment Asks Company for Quantitative Disclosure Related to Menu Price Impacts on Revenue Barnes & Thornburg LLP
Nov
14
2023
HHS-HRSA Terminates 340B Drug Pricing Program Registration Waiver Barnes & Thornburg LLP
Dec
13
2016
Major FDA Reform Bill Becomes Law: Medical Device Overview Barnes & Thornburg LLP
Jan
30
2017
New Jersey Supreme Court Deals Blow to Drug and Device Manufactures Seeking to Avoid Forum Shopping Barnes & Thornburg LLP
Jul
6
2017
State Budget Update: Impact on Ohio’s Opioid Crisis Barnes & Thornburg LLP
Jan
23
2018
Food, Drug, and Device Law Alert - FDA Proposes Defining "Significant Decision" in Safety and Innovation Act Barnes & Thornburg LLP
Mar
31
2014
EPA (Environmental Protection Agency) Proposes Rulemaking: Revising the Regulatory Definition of "Waters of the United States" Barnes & Thornburg LLP
May
2
2014
Promoting Renewable Energy Redevelopment of Brownfields - Formerly Contaminated Properties, Landfills and Mine Sites Barnes & Thornburg LLP
Apr
16
2015
FDA Proposes to Amend Regulations on Food Facility Registration Barnes & Thornburg LLP
May
11
2015
Amarin Pharma Preemptively Sues FDA over First Amendment Rights Barnes & Thornburg LLP
Nov
19
2019
Case Summaries Barnes & Thornburg LLP
Jun
30
2023
The O-1 Extraordinary Ability Visa: An Attractive Alternative to the H-1B Barnes & Thornburg LLP
Mar
18
2020
FDA Issues Final Guidance On Third-Party Review Of 510(K) Applications Barnes & Thornburg LLP
Jul
18
2016
FDA Amends Final Rule on Registration of Food Facilities Barnes & Thornburg LLP
Aug
15
2016
FDA Finalizes Guidance on General Wellness Devices, Will Not Regulate Barnes & Thornburg LLP
Oct
9
2023
Notable New California Employment Bills Signed Into Law – Part 1 Barnes & Thornburg LLP
Jun
30
2020
Ohio Appellate Court Rules That Insurer Must Defend Party Involved In Opioid MDL Barnes & Thornburg LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins